Could vitamin B3 prevent silent thief from stealing vision? New study finds protective effects against glaucoma
A study published in JAMA Ophthalmology suggests that nicotinamide, a form of vitamin B3, may significantly reduce the risk of developing glaucoma. Researchers found that patients taking the supplement were 66% less likely to develop the condition compared to non-users.
Why it matters
This research offers a potential low-cost, preventative therapeutic approach for a condition that is a leading cause of permanent vision loss.
edited by Sadie Harley , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Nicotinamide users were also less likely to develop glaucoma compared to non-users. Credit: Pexel. Often called the silent thief of sight, glaucoma is a group of eye diseases that gradually damage the optic nerve, often without warning signs. It is linked to increased pressure (ocular hypertension) inside the eye and, if left untreated, can lead to permanent vision loss. Even with ongoing treatment, some people still face the risk of progressive vision loss.
This led scientists to look for newer therapeutics that can help manage the disease's progression, such as nicotinamide, a form of vitamin B3.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in